Evaluation of in vitro activity of a new fluoroquinolone trovafloxacin (cp-99,219) compared with other anti-anaerobic antimicrobials against members of the Bacteroides fragilis group

International Journal of Antimicrobial Agents

Volumn 8, Issue 4, 1997, Pages 249-252

  Borobio, M V ^a,b   Suarez A I ^a   Ramirez E ^a   Perea, E J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Anaerobes; Bactcroides fragilis; Fluoroquinolones; Quinolones; Trovafloxacin (CP 99,219)

Indexed keywords

CEFOXITIN; CHLORAMPHENICOL; CIPROFLOXACIN; IMIPENEM; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTEROIDES FRAGILIS; CONTROLLED STUDY; DRUG ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030989928     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(97)00014-9     Document Type: Article

References (1)

1. Borobio MV, Pascual A. Perea EJ. Increasing resistance of B. fragilis group strains to metronidazole in Spain between 1977 and 1982. Eur J Clin Microbiol Infect Dis 1985;3:153-155.